Drug
Afegostat
Afegostat: highest development phase Phase 2, developed by Amicus Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Amicus Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| afegostat tartrate NCT00446550 | Phase 2 | Gaucher Disease |
| afegostat tartrate NCT00813865 | Phase 2 | Gaucher Disease |
Latest
No recent events.
Follow Afegostat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.